Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Therapeutics Inc ARTH

Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.


OTCQB:ARTH - Post by User

Post by Stockqueen77on Aug 06, 2021 2:10am
273 Views
Post# 33662180

AVTAR DHILLION ARRESTED, previous board chairman!

AVTAR DHILLION ARRESTED, previous board chairman!
A cannabis and biotechnology entrepreneur was arrested and charged with securities fraud over his secret sale of shares in two companies in which he served as board chairman. Avtar S. Dhillon, 60, executive chairman of medical marijuana firmEmerald Health Therapeutics Inc., was arrested Wednesday on charges brought by federal prosecutors in Boston, who said he made more than $2 million from the scheme. Dhillon, a Canadian national living in California, will make his initial appearance in federal court in Boston at a later date. A lawyer for Dhillon couldnt immediately be identified. Vancouver-based Emerald Health declined to comment on Dhillons arrest. According to the government, Dhillon concealed from regulators his ownership of millions of shares inArch Therapeutics Inc.andOncoSec Medical Inc., two microcap biotech firms. He was board chairman at Arch from 2013 to 2018 and OncoSec from 2011 to 2020. Dhillon and a co-conspirator made false and misleading representations in order to deposit and then sell the shares in the open market to unsuspecting investors, the government said. From 2005 to 2009, Dhillon was chief executive officer ofInovio Pharmaceuticals Inc.
<< Previous
Bullboard Posts